Fig. 3From: Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancerHypoxia increased radioresistance in the DU145 and PC3 cell lines. Cell survival curves for DU145 (a) and PC3 (b) cells, irradiated under normoxia or 0.1% O2. The data points represent the mean ± SEM of 2–4 values taken from each biological repeat. OERs were calculated at SF10% and statistical analysis was performed using the F-testBack to article page